3,4-di-substituted cyclobutene-1, 2 - diones as CXC chemokine receptor antagonists
Details for Australian Patent Application No. 2002303084 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 60/265,951 02.02.01 US
27 March 2003 Application Open to Public Inspection
Published as AU-B-2002303084
11 November 2004 Assignment before Grant
Schering Corporation; Pharmacopeia, Inc. The application has been assigned to Schering Corporation; Pharmacopeia Drug Discovery, Inc.
25 May 2006 Application Accepted
Published as AU-B-2002303084
21 September 2006 Standard Patent Sealed
20 September 2007 Change of Name(s) of Applicant(s), Section 104
Pharmacopiea Drug Discovery, Inc.; Schering Corporation The name of the applicant has been changed to Pharmacopiea, Inc.; Schering Corporation
28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser